A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA).
Grant D StewartSarah J WelshStephan UrsprungFerdia A GallagherJames O JonesJacqui ShieldsChristopher G SmithThomas J MitchellAnne Y WarrenAxel BexEkaterini BoletiJade CarruthersTim EisenKate FifeAbdel HamidAlexander LairdSteve LeungJahangeer MalikIosif A MendichovszkyFaiz MumtazGrenville OadesAndrew N PriestAntony C P RiddickBalaji VenugopalMichelle WelshKathleen RiddleLisa E M Hopcroftnull nullRobert J JonesPublished in: British journal of cancer (2022)
NCT03494816.